ABERRANT SPLICING DURING ERYTHROID DIFFERENTIATION IN SF3B1 MUTATED SIDEROBLASTIC

被引：0

作者：

Conte, S. ^{[1
]}

Vesterlund, L. ^{[2
,3
]}

Katayama, S. ^{[2
,3
,4
]}

Karimi, M. ^{[1
]}

Unneberg, P. ^{[5
]}

Papaemmanuil, E. ^{[6
]}

Jansson, M. ^{[1
]}

Mortera-Blanco, T. ^{[1
]}

Dimitriou, M. ^{[1
]}

Sander, B. ^{[7
]}

Skoog, T. ^{[2
,3
]}

Campbells, P. ^{[6
]}

Kere, J. ^{[2
,3
]}

Hellstrom-Lindberg, E. ^{[1
]}

机构：

[1] Ctr Hematol & Regenerat Med HERM, Dept Med, Huddinge, Sweden

[2] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden

[3] Karolinska Inst, Ctr Biosci, Stockholm, Sweden

[4] Sci Life Lab, Stockholm, Sweden

[5] Sci Life Lab, Dept Biochem & Biophys, Stockholm, Sweden

[6] Wellcome Trust Sanger Inst, Canc Genet & Genom, Cambridge, England

[7] Karolinska Univ Hosp, Div Pathol, Dept Lab Med, Stockholm, Sweden

来源：

HAEMATOLOGICA | 2013年 / 98卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P168

引用

页码：73 / 74

页数：2

共 50 条

[21] SF3B1: from core splicing factor to oncogenic driver
Bak-Gordon, Pedro
Manley, James L.
RNA, 2025, 31 (03) : 314 - 332
[22] Potential role of the splicing factor SF3B1 in epigenetic regulation
Deliard, Sandra
Okamoto, Yasuyuki
Madzo, Jozef
Jelinek, Jaroslav
Issa, Jean-Pierre
CANCER RESEARCH, 2017, 77
[23] SF3B1 Splicing Mutation in the Context of Therapy Related MDS
Volpe, Virginia Olivia
Al Ali, Najla
Chan, Onyee
Padron, Eric
Sallman, David A.
Komrokji, Rami S.
BLOOD, 2020, 136
[24] Characterization of the aberrant splicing of MAP3K7 induced by cancer-associated SF3B1 mutation
Li, Zhuang
Zhao, Bo
Shi, Yueru
Liang, Yuqi
Qian, Rui
Wan, Youzhong
JOURNAL OF BIOCHEMISTRY, 2021, 170 (01): : 69 - 77
[25] The Spliceosomal Component Sf3b1 Is Essential for Hematopoietic Differentiation
De La Garza-Sauceda, Adriana
Cameron, Rosannah C.
Nik, Sara
Gulfo, Michelle
Payne, Sara G.
Bowman, Teresa V.
BLOOD, 2015, 126 (23)
[26] SF3B1 mutations induce disease relevant aberrant mRNA splicing in cancer and confer sensitivity to spliceosome inhibition
Buonamici, S.
Lim, K.
Feala, J.
Darman, R.
Myint, K.
Park, E.
Aird, D.
Chan, B.
Fekkes, P.
Furman, R.
Keaney, G.
Kumar, P.
Kunii, K.
Puyang, X.
Thomas, M.
Mizul, Y.
Warmuth, M.
Zhu, P.
Yu, L.
Smith, P.
EUROPEAN JOURNAL OF CANCER, 2014, 50 : 149 - 149
[27] Altered DNA Methylation Profiles in SF3B1 Mutated CLL Patients
Pacholewska, Alicja
Grimm, Christina
Herling, Carmen D.
Lienhard, Matthias
Koenigs, Anja
Timmermann, Bernd
Altmueller, Janine
Muecke, Oliver
Reinhardt, Hans Christian
Plass, Christoph
Herwig, Ralf
Hallek, Michael
Schweiger, Michal R.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (17)
[28] Increased sensitivity of SF3B1 mutated uveal melanoma by spliceosome inhibition
Nguyen, Josephine
Drabarek, Wojtek
Leeflang, Aisha
Brands, Tom
van den Bosch, Thierry
Verdijk, Robert
van de Werken, Harmen
van Riet, Job
van der Horst, Niels
Medico-Salsench, Eva
Paridaens, Dion
de Klein, Annelies
Brosens, Erwin
Kilic, Emine
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
[29] Identification of high risk metastatic SF3B1 mutated uveal melanoma
Drabarek, W.
van Riet, J.
Nguyen, J.
de Bruyn, D.
Verdijk, R.
Naus, N.
Paridaens, D.
van de Werken, H.
de Klein, A.
Brosens, E.
Kilic, E.
ACTA OPHTHALMOLOGICA, 2021, 99 : 28 - 28
[30] ACCELERATED RNA SPLICING DYNAMICS DURING ERYTHROID DIFFERENTIATION AMPLIFY MIS-SPLICING IN SF3B1-MUTANT MDS-RS
Moura, P.
Mortera-Blanco, T.
Hofman, I.
Todisco, G.
Kretzschmar, W.
Bjorklund, A. -C.
Creignou, M.
Hagemann-Jensen, M.
Ziegenhain, C.
Granados, D.
Barbosa, I.
Walldin, G.
Jansson, M.
Mead, A.
Lundin, V.
Dimitriou, M.
Yoshizato, T.
Woll, P.
Ogawa, S.
Sandberg, R.
Jacobsen, S. E.
Hellstrom-Lindberg, E.
LEUKEMIA RESEARCH, 2023, 128

← 1 2 3 4 5 →